LIANYOTCPharmaceutical PreparationsFiscal year ends December 31
LianBio
Financials through Q3 FY2023, quarter ended Sep 30, 2023Last filing: 10-Q on Nov 13, 2023
$0.06+0.01 (+15.10%)
Close on Oct 19, 2026
- Market cap
- $6.29M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0.0%
0M of 108M shares
Institutional holders
1
0 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Tang Capital Partners, LP | 8,051,815 | 7.50% | 13G (passive) | Nov 8, 2024 |
| Joseph Edelman | 57,850,841 | 53.40% | 13D (active) amendment | Feb 29, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of LIANY | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| FNY Investment Advisers, LLC | 14,000 | 0.01% | $1 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q1 2026 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2025 | 1 | 0M | 0.0% | 0 / 0 | 1 / 0 | 0M | 0M |
| Q3 2025 | 1 | 0M | 0.0% | 0 / 1 | 0 / 0 | 0M | 0M |
| Q2 2025 | 1 | 0M | 0.0% | 0 / 0 | 1 / 0 | 0M | 0M |
| Q1 2025 | 1 | 0M | 0.0% | 0 / 1 | 0 / 1 | 0M | 0M |
| Q4 2024 | 2 | 0M | 0.1% | 0 / 1 | 0 / 0 | 0M | 0M |
| Q3 2024 | 2 | 0M | 0.1% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q2 2024 | 2 | 0M | 0.1% | 0 / 1 | 0 / 1 | 0M | 0M |
| Q1 2024 | 3 | 0M | 0.1% | 3 / 0 | 0 / 29 | 0M | 84M |
| Q4 2023 | 29 | 84M | 78.2% | 8 / 11 | 3 / 16 | 12M | 5M |
| Q3 2023 | 38 | 79M | 73.1% | 6 / 9 | 7 / 7 | 4M | 5M |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Ehong Gu Interim CFO | Apr 9, 2024 | Returned to company | −17,889 | $0.32 | $5.72K | 0 |
| Konstantin Poukalov Director | Feb 15, 2024 | Option exercise | +36,300 | $2.52 | $91.48K | 36,300 |
| Konstantin Poukalov Director | Feb 15, 2024 | Tax withholding | −19,218 | $4.76 | $91.48K | 17,082 |
| Adam Leo Stone Interim CEO, Director | Feb 15, 2024 | Tax withholding | −19,218 | $4.76 | $91.48K | 17,082 |
| Adam Leo Stone Interim CEO, Director | Feb 15, 2024 | Option exercise | +36,300 | $2.52 | $91.48K | 36,300 |
| Anastasios Gianakakos Director | Feb 15, 2024 | Option exercise | +36,300 | $2.52 | $91.48K | 72,848 |
| Anastasios Gianakakos Director | Feb 15, 2024 | Tax withholding | −19,218 | $4.76 | $91.48K | 53,630 |
| Life Sciences Master Fund Ltd Perceptive Director, 10% owner | Feb 15, 2024 | Tax withholding | −19,218 | $4.76 | $91.48K | 17,082 |
| Life Sciences Master Fund Ltd Perceptive Director, 10% owner | Feb 15, 2024 | Tax withholding | −19,218 | $4.76 | $91.48K | 17,082 |
| Life Sciences Master Fund Ltd Perceptive Director, 10% owner | Feb 15, 2024 | Option exercise | +36,300 | $2.52 | $91.48K | 36,300 |
| Life Sciences Master Fund Ltd Perceptive Director, 10% owner | Feb 15, 2024 | Option exercise | +36,300 | $2.52 | $91.48K | 36,300 |
| Susan Michele Silbermann Director | Feb 15, 2024 | Option exercise | +36,300 | $2.52 | $91.48K | 36,300 |
| Susan Michele Silbermann Director | Feb 15, 2024 | Tax withholding | −19,218 | $4.76 | $91.48K | 17,082 |
| Ehong Gu Interim CFO | Jan 2, 2024 | Sale | −1,731 | $4.34 | $7.51K | 76,762 |
| Jiang Qian SVP, China General Manager | Mar 29, 2023 | Award | +224,005 | – | – | 291,354 |
| Yi Larson Chief Financial Officer | Mar 29, 2023 | Award | +325,901 | – | – | 325,901 |
| Yizhe Wang Chief Executive Officer, Director | Mar 29, 2023 | Award | +907,498 | – | – | 907,498 |
| Brianne Jahn Chief Business Officer | Mar 29, 2023 | Award | +224,005 | – | – | 224,005 |
| Jiang Qian SVP, China General Manager | Jan 3, 2023 | Sale | −2,239 | $1.65 | $3.69K | 67,349 |
| LEV LB Holdings GP, LLC Director, 10% owner | Aug 18, 2022 | Buy | +998,240 | $2.40 | $2.40M | 3,728,491 |
| LEV LB Holdings, LP Director, 10% owner | May 26, 2022 | Buy | +69,000 | $3.13 | $215.97K | 2,730,251 |
| Perceptive Venture Advisors, LLC Director, 10% owner | May 25, 2022 | Buy | +120,000 | $2.63 | $315.60K | 2,661,251 |
| Perceptive Venture Advisors, LLC Director, 10% owner | May 24, 2022 | Buy | +42,551 | $2.47 | $105.10K | 2,541,251 |
| Perceptive Venture Advisors, LLC Director, 10% owner | May 23, 2022 | Buy | +8,700 | $2.49 | $21.66K | 2,498,700 |
| Debra Yu See Remarks | May 4, 2022 | Option exercise | +1,000,000 | $1.71 | $1.71M | 1,000,000 |
| Jiang Qian China General Manager | Dec 31, 2021 | Award | +69,588 | – | – | 69,588 |
| Anastasios Gianakakos Director | Dec 29, 2021 | Option exercise | +36,548 | $6.49 | $237.20K | 36,548 |
| LEV LB Holdings, LP Director, 10% owner | Nov 3, 2021 | Buy | +20,000 | $13.51 | $270.20K | 27,858,895 |
| LEV LB Holdings, LP Director, 10% owner | Nov 3, 2021 | Buy | +2,250,000 | $16.00 | $36.00M | 27,838,895 |
| Perceptive Venture Advisors, LLC 10% owner | Nov 3, 2021 | Conversion | +2,477,005 | – | – | 2,477,005 |
| Perceptive Venture Advisors, LLC 10% owner | Nov 3, 2021 | Conversion | +3,715,510 | – | – | 10,969,395 |
| Perceptive Venture Advisors, LLC 10% owner | Nov 3, 2021 | Conversion | +14,619,500 | – | – | 25,588,895 |
| Perceptive Venture Advisors, LLC 10% owner | Nov 3, 2021 | Conversion | +14,619,500 | – | – | 21,653,385 |
| Perceptive Venture Advisors, LLC 10% owner | Nov 3, 2021 | Conversion | +2,923,000 | – | – | 4,330,675 |
| Perceptive Venture Advisors, LLC 10% owner | Nov 2, 2021 | Buy | +100,000 | $13.50 | $1.35M | 7,253,885 |
| Perceptive Venture Advisors, LLC 10% owner | Nov 1, 2021 | Buy | +120,000 | $15.50 | $1.86M | 7,153,885 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Yizhe Wang Officer, OFFICER FORMER CEO | Jan 8, 2024 | 820,000 | $3.42M | Jan 8, 2024 | CASHLESS EXERCISE RELEASE SALE OF EMPLOYEE SHARE GRANTED UNDER COMPANY SHARE INCENTIVE PLAN |
| Yizhe Wang Officer, FORMER CEO | Dec 29, 2023 | 250,000 | $1.11M | Dec 29, 2023 | CASHLESS EXERCISE RELEASE SALE OF EMPLOYEE SHARES GRANTED UNDER SHARE INCENTIVE PLAN |